Back to results
US 2001/0020019 A1Published application
Novel halo-alkoxycarbonyl prodrugs
AssigneeGenentech, Inc.
InventorsBRENT BLACKBURN, ALAN G. OLIVERO, KIRK ROBARGE
Life of this patent
Estimating the term…
Abstract
Halo-alkoxycarbonyl derivatives are provided as prodrug moieties for pharmaceutical agents containing a basic or polar nitrogen containing functionality. The prodrugs are provided as pharmaceutical compositions as well as in methods of treatment.
Claims26
A compound of the formula:
- 15
- wherein [(H)0-2(X)1-3] is selected from the group consisting of X3, HX2, and H2X and X is a halogen selected from the group consisting of F, Cl, Br, I or a combination thereof;
- R2 and R3 are the same or different and are selected from the group consisting of H, C1-C4alkyl, C1-C4alkoxy, cyano, halo(F, Cl, Br, I)C1-C4alkyl and aryl, AG-Q is a biologically active pharmaceutical agent wherein Q is a basic N-containing functionality selected from the group consisting of an amino, amidino, aminoalkyleneamino, iminoalkyleneamino, and guanidino group.
A compound having one of the following two tautomeric structures:
- 20
- wherein AG represents a biologically active parent pharmaceutical agent substructure and wherein P and P′ are the same or different and are independently selected from H or a trichloroethoxycarbonyl moiety, at least one of P or P′ being a trichloroethoxycarbonyl moiety and B is selected from the group consisting of a substituted or unsubstituted alkyl, alkenyl or alkynyl, a substituted or unsubstituted aryl, arylalkyl, heterocyclic, and heteroaromatic.
Dependencies are inferred from the claim text.